Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14626 - 14650 of 14682 in total
TAK-475 is a "squalene synthase inhibitor", a type of cholesterol-lowering drug that has not yet been brought to market.
Investigational
Experimental
VLTS-589 consists of plasmid encoding the angiomatrix protein Del-1 in conjunction with poloxamer 188 for the treatment of peripheral vascular disease.
Investigational
Experimental
Experimental
Investigational
Experimental
Tozadenant has been investigated for the basic science of Cocaine Dependence.
Investigational
Experimental
Displaying drugs 14626 - 14650 of 14682 in total